Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-306110 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 16, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
13,053
Total Value
$119,046.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Exercise/Conversion | 4,351 | $3.98 | $17,316.98 | 66,722 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 15, 2026 | Sale | 4,351 | $23.38 | $101,729.86 | 62,371 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jul 15, 2026 | Exercise/Conversion | 4,351 | $0.00 | $0.00 | 26,947 | Direct | โ | View Details |